Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of CorVad Percutaneous Mechanical Circulatory Support in Patients with ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock.

NCT06886113 is registered in ClinicalTrials.gov with Shenzhen Core Medical Technology CO.,LTD. as lead sponsor.

NCT NCT06886113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06886113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of CorVad Percutaneous Mechanical Circulatory Support in Patients with ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock.
Lead sponsor
Shenzhen Core Medical Technology CO.,LTD.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
February 15, 2028
Enrollment
269 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock